Brind.

Gyre Therapeutics, headquartered in San Diego, is focused on developing therapies for MASH liver fibrosis.

1 report, 1 independent Updated Sep 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Gyre Therapeutics, headquartered in San Diego, is focused on developing therapies for MASH liver fibrosis.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireGyre Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, co